New York, NY -- (SBWIRE) -- 12/13/2013 -- CaddyStocks.com is keen to discover penny stocks with the potential to make short and long-term gains. We’ve been improving our skills as traders and analysts for years, and we know – from experience – which indicators to look for. That’s why we’ve been able to choice some of the market’s biggest winners and send them to our followers before the rest of the market has any idea of what hit them. Here are some hot stocks to watch for:- International Stem Cell Corp(OTCMKTS:ISCO), GT Advanced Technologies Inc(NASDAQ:GTAT), AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) , Buka Ventures Inc(OTCBB:NNRX)
International Stem Cell Corp(OTCMKTS:ISCO) plunged -2.92% and closed at $0.233 on a traded volume of 5.83M shares, in comparison to 689768 shares of average trading volume. The company has a total market capitalization of $30.89 million and its total outstanding shares are 132.59 million.
International Stem Cell Corporation is a developmental-stage biotechnology company. The Company focused on therapeutic, biomedical and cosmeceutical product. The Company’s wholly owned subsidiary Lifeline Cell Technology, LLC (Lifeline) develops manufactures and commercializes human cells and the reagents needed to culture and study human cells.
Has ISCO Found The Bottom and Ready To Move Up? Find Out Here
GT Advanced Technologies Inc(NASDAQ:GTAT) plunged -2.07% and closed at $8.05 on a traded volume of 7.64M shares, whereas its average trading volume is 7.15M shares. The Intra-day range for the stock is $2.61 and $10.75.
GT Advanced Technologies Inc. is diversified technology company with crystal growth equipment and solutions for the global solar, light emitting diode (LED) and electronics industries. The Company operates in three segments: its polysilicon business, its photovoltaic (PV), business and its sapphire business.
For How Long GTAT Gloss will Attract Investors? Find out via this report
AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) surged 10.00% and closed at $1.21. The 52-week range for the stock is $0.99 and $3.45 and during the previous trading session the stock touched its highest price at $1.123. Its introductory price for the day was $1.08, with the overall traded volume of 4.41M shares.
Aeterna Zentaris Inc. (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval. Its lead oncology program is an ongoing Phase 3 trial in endometrial cancer with zoptarelin doxorubicin (formerly AEZS-108). Its lead endocrinology product is macimorelin acetate (formerly AEZS-130) for which an NDA has been submitted to the FDA, seeking approval for the marketing and sales of macimorelin acetate as the first orally-administered product that induces growth hormone release to evaluate Adult Growth Hormone Deficiency (AGHD). Its pipeline also encompasses other earlier-stage programs in both oncology and endocrinology.
Will AEZS Continue To Move Higher? Find Out Here
Buka Ventures Inc(OTCBB:NNRX) after opening its trade at the price of $0.51,plunged -13.46% to close at $0.450 for the day. The stock moved on a traded volume of 2.99M shares, in comparison to 2.49M shares of average trading volume.The 52-week range for the stock is $0.126 and $1.480 and during the previous trading session the stock ouched its highest price at $0.52.
Nutranomics, Inc. researches and develops nutritional food products. Its nutritional products include supplements for joint health, digestive enzymes, whole food multi-vitamin, antioxidants, pre and probiotic, immune support, hormone balance, stress/sleep, detox/cleanse, natural vitamin C
Why Should Investors Buy NNRX After The Recent Gain? Just Go Here and Find Out
CaddyStocks record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
The employees of CaddyStocks.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
The information contained in the website and in any reports is provided on an “as-is” basis and has not been verified by us. All information on profiled companies is provided by such companies, or is available from public sources and no representation; warranty or guaranty is made as to its accuracy or completeness. CaddyStocks.com is under no obligation to update any information or opinions contained herein. Investors should not rely solely on the information presented herein, but rather use such information as a starting point for doing additional independent research on the profiled companies in order to form investment strategies and decisions. Neither CaddyStocks.com nor any of its owners, operators, or affiliates shall be liable to any subscriber or reader for any losses or damages arising from the use of any information contained herein, caused in whole or part by CaddyStocks.com in procuring, compiling, interpreting, reporting, or delivering any of the information contained herein or otherwise delivered.
Read Full Disclaimer at: http://caddystocks.com/disclaimer.html/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)